FDA Approves OLANZAPINE — Dr. Reddy's Laboratories Inc.

# FDA Approves Dr. Reddy's Generic Olanzapine, Expanding Antipsychotic Competition Dr. Reddy's Laboratories Inc. received FDA approval for its generic olanzapine oral formulation, strengthening the company's psychiatry portfolio and enabling it to capture market share in the large antipsychotic segment as the original brand-name patent protections expire. The approval positions Dr. Reddy's to compete directly with established generic competitors in a therapeutic area with significant demand from managed care providers seeking cost-effective alternatives to branded olanzapine.